Alnylam Pharma Stock Performance
as on August 19, 2026 at 3:30 am IST
Day's Low
Day's High
$222.01$230.22
3.53%
Downside
0.03%
Upside
52 Week's Low
52 Week's High
$197.81$495.5514.05%
Downside
115.33%
Upside
Alnylam Pharma share price movements today
- Previous Close
- $224.60
- Open
- $225.85
- Volume
- 467.2K
- Market Cap
- $30.6B
- Day's Low - High
- $222.01 - $230.22
- 52 Week Low - High
- $197.81 - $495.55
Alnylam Pharma Historical Returns
- 1 Month Return
- -14.51 %
- 3 Month Return
- -20.33 %
- 1 Year Return
- -49.07 %
- 3 Year Return
- + 24.34 %
- 5 Year Return
- + 14.18 %
Alnylam Pharma Stock Fundamentals & Key Indicators
Check Alnylam Pharma market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$30.6B
EPS (TTM)
8.9154
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
39.83
Industry PE ratio
10.197
PEG Ratio
0.4344
EBITDA
1.1B
Revenue (TTM)
4.8B
Profit Margin
16.13%
Return On Equity TTM
96.56%
Alnylam Pharma Stock Valuation
Track how Alnylam Pharma P/E has moved over time to understand its valuation trends.
Alnylam Pharma in the last 5 years
Lowest (-99.61x)
December 31, 2023
Industry (10.20x)
August 17, 2026
Today (39.83x)
August 17, 2026
Highest (124.53x)
September 30, 2025
Today’s Price to Earnings Ratio: 39.83x
Alnylam Pharma vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Alnylam Pharma with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| BUY | $30.6B | 14.18% | 39.83 | 16.13% | NA | |
| BUY | $43.7B | 669.3% | NA | 0.00% | NA | |
| BUY | $128.2B | 154.86% | 29.82 | 86.04% | NA | |
| BUY | $82.7B | 24.1% | 19.24 | 84.86% | 0.44999999999999996% |
Stock Returns calculator for Alnylam Pharma Stock including INR - Dollar returns
The Alnylam Pharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Alnylam Pharma investment value today
Current value as on today
₹56,175
Returns
Returns from Alnylam Pharma Stock
Dollar Impact
₹4,908 (+4.91%)
Analyst Recommendation on Alnylam Pharma Stock
Based on 19 analysts
84.21%
Buy
15.79%
Hold
0.00%
Sell
Based on 19 analysts, 84.21052631578947% of analysts recommend a 'BUY' rating for Alnylam Pharma. Average target price of $372.29
Alnylam Pharma Share Price Target
Get share price movements and forecasts by analysts on Alnylam Pharma.
What analysts predicted
38.18%UPSIDE
Target Price
$372.29
Current Price
$230.14
Analyzed by
19 Analysts
Target
$372.29
Alnylam Pharma target price $372.29, a slight upside of 38.18% compared to current price of $230.14. According to 19 analysts rating.
Indian Investors' Interest in Alnylam Pharma Stock
Investment in Alnylam Pharma Shares on INDmoney has grown by 150.98% in the last 30 days, indicating increased investment activity.
Time period: to
Change:150.98% versus previous 30 day period
Search interest for Alnylam Pharma Stock has increased by 171% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:171% versus previous 30 day period
Alnylam Pharma Quarterly Profit & Loss
All numbers in Millions USD
Alnylam Pharma Annual Profit & Loss
All numbers in Millions USD
Alnylam Pharma Quarterly Cash Flow
All numbers in Millions USD
Alnylam Pharma Annual Cash Flow
All numbers in Millions USD
Alnylam Pharma News & Key Events
Today's Timeline - 30 July
Fri, 05:52 AM
-Alnylam's Q2 2026 earnings call highlights record AMVUTTRA sales exceeding $1 billion, but lowers TTR revenue guidance.
Insights on Alnylam Pharma
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 3 quarters, 1.09B → 1.29B (in $), with an average increase of 7.8% per quarter
NO EFFECTAgainst Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 615.7% return, outperforming this stock by 595.0%
- NO EFFECT
Against Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 481.6% return, outperforming this stock by 532.4%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 2 quarters, 205.99M → 164.49M (in $), with an average decrease of 20.2% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 1 month, ALNY stock has moved down by -16.0%
About Alnylam Pharma
| Organisation | Alnylam Pharma |
| Headquarters | 675 West Kendall Street, Cambridge, MA, United States, 02142 |
| Industry | Biotechnology |
| CEO | Dr. Yvonne L. Greenstreet M.B.A., M.D. |
| E-voting on shares | Click here to vote |
Key Management of Alnylam Pharma
Name | Title |
|---|---|
Mr. Jeffrey V. Poulton M.B.A. | CFO & Executive VP |
Dr. Pushkal P. Garg M.D. | Executive VP & Chief Research & Development Officer |
Ms. Melissa McLaughlin M.B.A. | Chief Human Resources Officer |
Dr. Yvonne L. Greenstreet M.B.A., M.D. | CEO & Director |
Dr. Phillip A. Sharp Ph.D. | Co-Founder, Member of the Scientific Advisory Board |
Dr. Kevin Joseph Fitzgerald Ph.D. | Executive VP, Chief Scientific Officer and Head of Early Research & Early Development |
Mr. Joshua Brodsky | Vice President of Investor Relations |
Mr. Piyush Sharma J.D. | Chief Ethics & Compliance Officer |
Mr. Bryan Andrew Supran J.D. | Chief Legal Officer |
Mr. Timothy J. Maines | Chief Technical Operations & Quality Officer |
FAQs
What is Alnylam Pharma share price today?
Alnylam Pharma share price today is $230.14 as on . Alnylam Pharma share today touched a day high of $230.22 and a low of $222.01.
What is the 52 week high and 52 week low for Alnylam Pharma share?
Alnylam Pharma share touched a 52 week high of $495.55 on and a 52 week low of $197.81 on . Alnylam Pharma stock price today i.e. is trending at $230.14,which is 53.56% down from its 52 week high and 16.34% up from its 52 week low.
What is Alnylam Pharma's market capitalisation today?
Alnylam Pharma market capitalisation is $0.03T as on .
How to invest in Alnylam Pharma Stock (ALNY) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Alnylam Pharma on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Alnylam Pharma Shares that will get you 0.0065 shares as per Alnylam Pharma share price of $230.14 per share as on August 18, 2026 at 10:00 pm IST.
What is the minimum amount required to buy Alnylam Pharma Stock (ALNY) from India?
Indian investors can start investing in Alnylam Pharma (ALNY) shares with as little as ₹95.67 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹956.70 in Alnylam Pharma stock (as per the Rupee-Dollar exchange rate as on ).
Based on Alnylam Pharma share’s latest price of $230.14 as on August 18, 2026 at 10:00 pm IST, you will get 0.0435 shares of Alnylam Pharma. Learn more about
fractional shares .
What are the returns that Alnylam Pharma has given to Indian investors in the last 5 years?
Alnylam Pharma stock has given 14.18% share price returns and 28.34% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?